Join us Sept. 14 as this year’s symposium series kicks off with a talk from Dr. Marianne Cloeren, School of Medicine associate professor and UMB Public Health Officer.
Join us on Sept. 14 from 4 p.m. to 5:15 p.m., as Marianne Cloeren, MD, MPH, begins this year’s President’s Symposium series discussing opioid addiction, treatment, and prevention.
Dr. Cloeren was recently appointed as the 2022-2023 faculty advisor for the President’s Symposium and White Paper Project, which will see a group of several interprofessional students from UMB’s seven schools conduct a research project exploring UMB’s role in preparing health and human services professionals in addressing opioid addiction, treatment, and prevention.
Dr. Cloeren, associate professor at the University of Maryland School of Medicine and UMB’s Public Health Officer, comes to the President’s Symposium with extensive public health experience conducting research on occupational health and opioid recovery. In 2018, Dr. Cloeren mobilized an interdisciplinary team of researchers that received two grants in 2019 — the Institute for Clinical Translational Research (ICTR) Accelerated Translational Incubator Pilot (ATIP) grant and the Center for Addiction Research, Education and Services (CARES) Science to Systems grant — to study the work status and barriers to work in patients receiving Medication Assisted Treatment for Opioid Use Disorder in UMB clinical centers.
Furthermore, Dr. Cloeren joined forces with Dr. Jodi Jacobson Frey to study barriers to employment faced by adults in recovery from opioid use disorders, focusing on how employers can support employees recovering from opioid addiction.